Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2003
06/12/2003US20030109702 Fungicides, bactericides
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109538 Pyrmidine derivatives as selective inhibitors of cox-2
06/12/2003US20030109533 New benzenesulphonamide compounds
06/12/2003US20030109530 Diabetes, insulin resistance, dyslipidemia, obesity, high blood pressure, atherosclerosis, retinopathies and neurodegenerative disorders; synthesis by reacting a biguanide with an aldehyde, semiacetal or acetal in presence of acid catalyst
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003CA2469395A1 Novel inhibitor compounds specific of secreted non-pancreatic human a2 phospholiphase of group ii
06/12/2003CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
06/12/2003CA2468827A1 Insulin resistance improving agents
06/12/2003CA2468067A1 Metabotropic glutamate receptor-5 modulators
06/12/2003CA2463794A1 Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof
06/11/2003EP1318150A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
06/11/2003EP1317511A1 Oxazine derivatives
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317451A1 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317445A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317416A2 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP0956283B1 Substituted phenyltriazolin(thi)ones and their use as herbicides
06/11/2003CN1423649A Sulfonyl oxazole amines and their use as 5-HT6 receptor ligand
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423643A Method for the preparation of 5-cyanophthalide
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1422844A Intermediate for preparing substitated biphenyl oxazoline compounds
06/10/2003US6576762 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
06/10/2003US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor
06/10/2003US6576656 Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/10/2003CA2040489C 4-¬3-(4-oxothiazoldinyl)|butynylamines, a process for their preparation and their use as medicaments
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045941A1 Pyridine and pyrimidine derivatives
06/05/2003WO2003045939A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/05/2003WO2003045929A1 Bicyclic derivative, process for producing the same, and use
06/05/2003WO2003045928A1 Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
06/05/2003WO2003045925A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045901A2 Guanidine derivatives
06/05/2003WO2003045898A1 Prodrugs of excitatory amino acids
06/05/2003WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/05/2003WO2003045382A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045307A2 Pharmaceutical formulations comprising indolinone derivatives
06/05/2003WO2003014094A3 Heterocyclic aryl sulphonamides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105343 Benzofuran compounds
06/05/2003US20030105330 Synthesis of epothilones, intermediates thereto and analogues thereof
06/05/2003US20030105144 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105099 Novel compounds and compositions as cathepsin inhibitors
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105073 For therapy of cancer, inflammatory disorders, autoimmune disorders, psoriatic disorders and viral disorders
06/05/2003US20030105071 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467165A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003CA2466807A1 Pharmaceutical formulations comprising indolinone derivatives
06/05/2003CA2463592A1 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/04/2003EP1315733A2 Method for producing anellated tetrahydro-[1h]-triazoles
06/04/2003EP1315720A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315710A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1315490A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1144407B1 Cyclic guanidine derivatives and their use as pesticides
06/04/2003EP1084127B1 Organometallic complex molecule and organic electroluminescent device using the same
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0968208B1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0809637B1 Fungicidal aza-heterocycloalkenes
06/04/2003CN1422267A Processes for the preparation of thiazolidinedione derivatives and intermediates
1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 647